Molecular mechanisms and treatment modalities in equine Culicoides hypersensitivity.
Authors: Fettelschoss-Gabriel Antonia, Birkmann Katharina, Pantelyushin Stanislav, Kündig Thomas M
Journal: Veterinary journal (London, England : 1997)
Summary
Equine Culicoides hypersensitivity (CH) remains the most prevalent allergic skin condition in horses, yet understanding of its immunological basis has lagged behind human allergology. Through synthesis of current immunopathological evidence, this review identifies eosinophils and Th2 cell polarisation—particularly following prolonged allergen exposure—as central drivers of disease severity, proposing mechanistic parallels between equine and human allergic responses. Beyond conventional allergen avoidance and symptomatic management, the authors highlight emerging molecular targets with therapeutic potential: interleukin-5 (IL-5) inhibition to reduce hypereosinophilia, and interleukin-31 (IL-31) blockade to address non-histaminic pruritic pathways that traditional antihistamines fail to control. Allergen-specific immunotherapy remains valuable, though the review suggests its efficacy may be enhanced by simultaneous modulation of these downstream inflammatory mediators rather than used in isolation. For practitioners managing CH cases—particularly those refractory to conventional treatment—this framework offers evidence-based rationale for exploring targeted biological interventions alongside established management strategies, whilst underscoring the need for further equine-specific research to validate promising immunological targets.
Read the full abstract on PubMed
Practical Takeaways
- •Culicoides hypersensitivity is manageable through multiple strategies: traditional allergen avoidance/immunotherapy plus newer targeted treatments blocking IL-5 and IL-31 may improve outcomes in chronic cases
- •Understanding the Th2/eosinophil axis helps explain why some horses remain symptomatic despite allergen reduction, and suggests when to pursue advanced immunological treatments
- •Work with your veterinarian to consider both allergen-specific approaches and allergen-independent biological therapies, particularly in severe or refractory cases
Key Findings
- •Eosinophils play a central role in the immunopathology of equine Culicoides hypersensitivity
- •Chronic allergen exposure drives sustained Th2 cell responses that increase disease severity
- •Interleukin-5 and interleukin-31 are key molecular targets for treating hypereosinophilia and allergic pruritus independent of allergen avoidance
- •Allergen-specific immunotherapy and emerging biologics targeting specific cytokines offer complementary treatment approaches